FDA Approves First PCSK9 Pill for High Cholesterol | Global News

FDA just approved a game-changing new cholesterol pill called Lipfendra — the first oral drug that targets PCSK9 protein, slashing LDL by over 55% in just six months. For patients who still struggle with high cholesterol despite statins, this pill offers a cheaper, easier alternative to pricey shots. With heart disease still the top killer in the U.S., Lipfendra could be a major breakthrough — and it’s already on fast-track approval. Just remember: take it on an empty stomach. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/1158e791e96baedb